Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data

被引：0
|
作者：
Heran Deng
Liying Wang
Na Wang
Kejin Zhang
Yanxia Zhao
Pengfei Qiu
Xiaowei Qi
Danhua Zhang
Fei Xu
Jieqiong Liu
机构：
[1] Sun Yat-Sen Memorial Hospital,Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Tumor Center
[2] Sun Yat-Sen University,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[3] Sun Yat-Sen University Cancer Center,undefined
[4] Sun Yat-Sen University,undefined
[5] Xiangya Hospital of Central South University,undefined
[6] Center South University,undefined
[7] Union Hospital Tongji Medical College Huazhong University of Science and Technology,undefined
[8] Huazhong University of Science and Technology,undefined
[9] Shandong Tumor Hospital,undefined
[10] Shandong university,undefined
[11] The Southwest Hospital of AMU,undefined
[12] Army Medical University,undefined
[13] The Second Xiangya Hospital of Central South University,undefined
[14] Center South University,undefined
来源：
BMC Cancer | / 23卷
关键词：
Tripe-negative breast cancer; Neoadjuvant immunotherapy; Anti-PD-1/L1 antibody; Real-world study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data
    Deng, Heran
    Wang, Liying
    Wang, Na
    Zhang, Kejin
    Zhao, Yanxia
    Qiu, Pengfei
    Qi, Xiaowei
    Zhang, Danhua
    Xu, Fei
    Liu, Jieqiong
    BMC CANCER, 2023, 23 (01)
  • [2] Efficacy and safety of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancer: Real-world data
    Rached, L. W.
    Spotti, M. P.
    Baldini, C.
    Laparra, A.
    Remote, C. A. Dutertre
    Sakkal, M.
    Perret, A.
    Viansone, A. A.
    Zeghondy, J. Z.
    Rassy, E.
    Bousrih, C.
    Abdayem, P.
    Abboud, R. M. Khoury
    El Masri, H. K.
    Grinda, T.
    Terencio, S. Moragon
    Verret, B.
    Champiat, S.
    Pistilli, B.
    Ribeiro, J. T. M. L.
    ANNALS OF ONCOLOGY, 2023, 34 : S288 - S288
  • [3] Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer
    Pereira, Maria Fernanda Imperio
    Buzatto, Isabela Panzeri Carlotti
    Carrara, Helio Humberto Angotti
    Buono, Fabiana de Oliveira
    de Andrade, Jurandyr Moreira
    Orlandini, Leonardo Fleury
    Tiezzi, Daniel Guimaraes
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2024, 46
  • [4] Efficacy and safety of adding carboplatin in neoadjuvant chemotherapy for triple-negative breast cancer - real-world data
    Leung, K. H.
    Kwok, C. C. H.
    BREAST, 2025, 80
  • [5] Neoadjuvant chemotherapy for early breast cancer in young patients: real-world outcomes
    Javed, S. R.
    Mathur, S.
    Desouza, K.
    Konstantis, A.
    Ottaviani, D.
    Raja, F.
    Roylance, R.
    Walsh, T.
    Papadimitraki, E.
    CLINICAL ONCOLOGY, 2025, 38
  • [6] Impact of neoadjuvant Chemotherapy Regimen on Outcome in Patients with triple negative Breast Cancer: Real World Data
    Hatzipanagiotou, M. E.
    Zeltner, V.
    Gerken, M.
    Pigerl, M. C.
    Raepple, S.
    Roth, J.
    Ortmann, O.
    Klinkhammer-Schalke, M.
    Seitz, S.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (06) : E35 - E35
  • [7] Real-world outcomes in patients receiving neoadjuvant chemotherapy for early-stage triple-negative breast cancer
    Rhodes, Whitney C.
    Gautam, Santosh
    Haiderali, Amin
    Huang, Min
    Sieluk, Jan
    Skinner, Karen E.
    Schwartzberg, Lee S.
    CANCER RESEARCH, 2020, 80 (04)
  • [8] Breast cancer in Twitter: A real-world data exploratory study
    Bayona, R. Sanchez
    Chang-Azancot, L.
    Alvarez de Mon, M. A.
    Llavero, M.
    Vallejo, M.
    Gardeazabal, I.
    Salas, D.
    Sala Elarre, P.
    Baraibar Argota, I.
    Eguren, I.
    Santisteban Eslava, M.
    Ceniceros, L.
    Castanon Alvarez, E.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Dose-dense neoadjuvant chemotherapy in triple-negative breast cancer: Real-world data from a developing country
    Sharma, Rakesh Kumar
    Gogia, Ajay
    Deo, S. V. S.
    Sharma, Dayanand
    Mathur, Sandeep
    Sagiraju, Hari Krishna Raju
    INDIAN JOURNAL OF CANCER, 2023, 60 (04) : 505 - 511
  • [10] Real-world efficacy and safety of neoadjuvant pembrolizumab plus chemotherapy in Brazilian patients with earlystage triple-negative breast cancer
    Sousa, Isadora
    Comini, Ana Carolina M.
    Borges, Italo
    Balint, Flavia C.
    Martins, Livia Alexandre
    Sousa, Debora G.
    Sanches, Solange M.
    Cesca, Marcelle G.
    Cordeiro de Lima, Vladmir
    Tavares, Monique
    CANCER RESEARCH, 2024, 84 (09)
12345